Open AccessGrowth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody
Author(s) -
Judith Pichler,
Wolf Dietrich Huber,
Christoph Aufricht,
Bettina Bidmon-Fliegenschnee
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i21.6613
Subject(s) - medicine , body mass index , gastroenterology , bone mineral , anthropometry , infliximab , adalimumab , crohn's disease , tumor necrosis factor alpha , disease , osteoporosis
To study whether adalimumab (ADA) was associated with improvement in growth, bone mineral density (BMD) and bone metabolism.